| Title | Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies. |
| Publication Type | Journal Article |
| Year of Publication | 2024 |
| Authors | Kim Y, Maltseva N, Tesar C, Jedrzejczak R, Endres M, Ma H, Dugan HL, Stamper CT, Chang C, Li L, Changrob S, Zheng N-Y, Huang M, Ramanathan A, Wilson P, Michalska K, Joachimiak A |
| Journal | iScience |
| Volume | 27 |
| Issue | 2 |
| Pagination | 108976 |
| Date Published | 2024 Feb 16 |
| ISSN | 2589-0042 |
| Abstract | Coronavirus nucleocapsid protein (NP) of SARS-CoV-2 plays a central role in many functions important for virus proliferation including packaging and protecting genomic RNA. The protein shares sequence, structure, and architecture with nucleocapsid proteins from betacoronaviruses. The N-terminal domain (NPRBD) binds RNA and the C-terminal domain is responsible for dimerization. After infection, NP is highly expressed and triggers robust host immune response. The anti-NP antibodies are not protective and not neutralizing but can effectively detect viral proliferation soon after infection. Two structures of SARS-CoV-2 NPRBD were determined providing a continuous model from residue 48 to 173, including RNA binding region and key epitopes. Five structures of NPRBD complexes with human mAbs were isolated using an antigen-bait sorting. Complexes revealed a distinct complement-determining regions and unique sets of epitope recognition. This may assist in the early detection of pathogens and designing peptide-based vaccines. Mutations that significantly increase viral load were mapped on developed, full length NP model, likely impacting interactions with host proteins and viral RNA. |
| DOI | 10.1016/j.isci.2024.108976 |
| Custom 1 | |
| Alternate Journal | iScience |
| PubMed ID | 38327783 |
| PubMed Central ID | PMC10847736 |
| Grant List | 75N93019C00051 / AI / NIAID NIH HHS / United States 75N93022C00035 / AI / NIAID NIH HHS / United States HHSN272201700060C / AI / NIAID NIH HHS / United States P01 AI165077 / AI / NIAID NIH HHS / United States |
